Wei Liu

An Inhibitor of Mutant IDH1 Delays Growth and Promotes Differentiation of Glioma Cells

Dan Rohle, Janeta Popovici-Müller, Nicolaos Palaskas et al. · Science · 2013 · 1.2K citations

Medicine, Cancer Biology, Oncology +17

Structure of the human histamine H1 receptor complex with doxepin

Tatsuro Shimamura, Mitsunori Shiroishi, Simone Weyand et al. · Nature · 2011 · 803 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +12

Resensitization to Crizotinib by the Lorlatinib<i>ALK</i>Resistance Mutation L1198F

Alice T. Shaw, Luc Friboulet, Ignaty Leshchiner et al. · New England Journal of Medicine · 2015 · 484 citations · Full text

Medicine, Oncology, Pharmacology +16

PF-06463922 is a potent and selective next-generation ROS1/ALK inhibitor capable of blocking crizotinib-resistant ROS1 mutations

Helen Y. Zou, Qiuhua Li, Lars D. Engstrom et al. · Proceedings of the National Academy of Sciences · 2015 · 269 citations · Full text

Medicine, Oncology, Pharmacology +15

Modulation of morphogenesis by noncanonical Wnt signaling requires ATF/CREB family–mediated transcriptional activation of TGFβ2

Wenlai Zhou, Lizhu Lin, Årindam Majumdar et al. · Nature Genetics · 2007 · 180 citations · Full text

Life Sciences, Developmental Biology, Molecular Biology +16